SC 13D Filing

Company

REGENERON PHARMACEUTICALS, INC.

Filed

January 14, 2014

Accession Number

0000909518-14-000012

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →